The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study
Publication
, Conference
Visco, C; Tzankov, A; Xu-Monette, ZY; Miranda, RN; d'Amore, ESG; Montes-Moreno, S; Dybkaer, K; Chiu, A; Tam, W; Orazi, A; Zu, Y; Bhagat, G ...
Published in: BLOOD
November 18, 2011
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
433 / 434
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Visco, C., Tzankov, A., Xu-Monette, Z. Y., Miranda, R. N., d’Amore, E. S. G., Montes-Moreno, S., … Young, K. H. (2011). The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study. In BLOOD (Vol. 118, pp. 433–434). San Diego, CA: AMER SOC HEMATOLOGY.
Visco, Carlo, Alexander Tzankov, Zijun Y. Xu-Monette, Roberto N. Miranda, Emanuele S. G. d’Amore, Santiago Montes-Moreno, Karen Dybkaer, et al. “The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study.” In BLOOD, 118:433–34. AMER SOC HEMATOLOGY, 2011.
Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, d’Amore ESG, Montes-Moreno S, et al. The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 433–4.
Visco, Carlo, et al. “The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 433–34.
Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, d’Amore ESG, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Kahl BS, Winter JN, Wang H-Y, Dunphy CH, Hsi ED, Zhao FX, Go RS, Choi WWL, Zhou F, Czader M, Zhao X, Van Krieken JHJM, Huang Q, Ai W, Etzell JE, Ponzoni M, Ferreri AJM, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Young KH. The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 433–434.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
433 / 434
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology